A prospective study investivating the relationship between vitamin B6 status and cytopenias in patients with hematological disorders.

A prospective study investivating the relationship between vitamin B6 status and cytopenias in patients with hematological disorders. - Vitamin B6 status and cytopenias in hematological disorders.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017834

Enrollment

150

Registered

2015-06-24

Start date

2015-06-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hematological disorders

Interventions

Intervention in patients with low vitamin B6 levels will begin with oral administration of 6 tablets of Pydoxal 10mg tablets (Pyridoxal Phosphate Hydrate) per day, and if vitamin B6 levels are not ele

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients over 20 years old with a hematological disorder associated with cytopenias

Exclusion criteria

Exclusion criteria: 1. patients with Parkinson's disease or Parikinson's syndrome 2. patients under treatment with levodopa

Design outcomes

Primary

Measure	Time frame
hemoglobin and transfusion frequencies after administration of vitamin B6	—

Countries

Japan

Contacts

Public ContactHajime Yasuda

Juntendo University Hospital Department of Hematology

hyasuda@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026